A prospective study on Foxp3+CD25highCD4+ regulatory T cells in chronic hepatitis C infected patients undergoing direct-acting antiviral combination therapy

Assessment of CD4+CD25+ Regulatory T Lymphocytes Cells in Chronic Hepatitis C, Chronic Hepatitis C– Associated Cirrhosis and Hepatocellular Carcinoma Patients

ROLE OF T REGULATORY CELLS IN CHRONIC HCV INFECTED EGYPTIAN PATIENTS AND THEIR IMPACT ON THE RESPONSE TO PEGYLATED INTERFERON THERAPY

Liver Fibrosis as a Predictive Factor of Response to Pegylated-IFN/ Ribavirin Therapy in Chronic HCV Patients

Assessment of Degree of Fibrosis in Chronic Hepatitis C Virus Patients Treated with Direct Acting Antiviral Agents

Assessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin.

Assessment of the Level of Soluble CD25 as a Marker for the Detection of Hepatocellular Carcinoma in Chronic Hepatitis C virus (HCV) Infected Patients

Predictive value &changes in Child-Pugh score in chronic hepatitis C cirrhotic patients treated with Direct Acting Antiviral agents

Prognostic Value of Serum Retinoic Acid Receptor Responder Protein 2 (RARRES2) in Chronic Hepatitis C Patients

Interleukin 28b Single Nucleotide Polymorphism (rs8099917) as a Predictive Factor of Response to Pegylated-IFN/Ribavirintherapy in Chronic HCV Patients